Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Oropharyngeal Neoplasms × atezolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Triple Negative Breast Neoplasms 13 Carcinoma, Transitional Cell 12 Breast Neoplasms 12 Urinary Bladder Neoplasms 11 Small Cell Lung Carcinoma 10 Neoplasms 8 Melanoma 8 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 5 Lung Neoplasms 5 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Lymphoma 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Radiotherapy, Intensity-Modulated 10 Cisplatin 9 Cetuximab 4 Carboplatin 4 Radiotherapy 3 fludarabine phosphate 2 fludarabine 2 durvalumab 2 aldesleukin 2 Restraint, Physical 2 Radiation 2 Nivolumab 2 Cyclophosphamide 2 Bupropion 2 Acupuncture Therapy 2 utomilumab 1 pembrolizumab 1 ficlatuzumab 1 Transcutaneous Electric Nerve Stimulation 1 Tobacco Use Cessation Devices 1 Therapeutics 1 Sugars 1 Standard of Care 1 Psychiatric Rehabilitation 1 Pregabalin 1 Polymerase Chain Reaction 1 Platinum 1 Pilocarpine 1 Palliative Care 1 Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡